Cytomegalovirus (CMV) is a well-known opportunistic infection in immunocompromised hosts (1, 2). Cutaneous CMV infection has rarely been described and has variable clinical presentations (1-3), especially in patients with autoimmune bullous disease.
CMV IgM was negative. The viral load was 1.63 × 10 5 copies/ ml. He had no evidence of other organ involvement, such as eye, lung, or gastrointestinal tract. The prednisolone dose was tapered to 10 mg daily, and a he was put on a 10-day course of valacyclovir, 3 g daily. Serial CMV viral load decreased gradually, and repeated testing for CMV IgM remained negative. His lesions started to re-epithelialize thereafter (Fig. 1C) . The time-course of pemphigus disease area index, medications, body surface area of yellowish necrotic tissue, and results of laboratory examination are summarized in Fig. 3 .
DISCUSSION
The most common cutaneous presentations of cutaneous CMV are genital, and perianal ulcers (1, 2). The actual incidence of cutaneous CMV is unknown, partly due to non-specific clinical feature and possible false negativity of routine haematoxylin and eosin staining (1) . The hosts of previously reported cutaneous CMV have mainly been immunocompromised with human immunodeficiency virus (HIV) infection (3), haematological malignancy, or post-organ-transplantation (2) . CMV diseases in patients with autoimmune bullous disease have rarely been reported. Only 2 cases, one CMV-associated gastric ulcer in a patient with pemphigus vulgaris (4) and another patient with bullous pemphigoid developing disseminated CMV disease (5), have been reported.
Co-infection of CMV with other human herpes virus, mostly HSV and varicella-zoster virus (VZV), is common in HIV-positive patients, putting the pathogenetic role of CMV in cutaneous lesions in question (3). However, Choi et al. (2) conducted a study in 9 non-AIDS, immunocompromised patients, which revealed that CMV skin lesions were not highly associated with HSV. They proposed instead that CMV contributes to skin lesions in these patients. Rituximab, a human/mouse chimeric IgG-κ monoclonal antibody directed against the CD20 antigen expressed on most B cells, is widely used to treat B-cell lymphomas, chronic lymphocytic leukaemia, transplant rejection, and various autoimmune diseases (6) . CMV reactivation and disease after rituximab has been increasingly recognized (7, 8) . In our case, 2 doses of rituximab were administered, but how much the rituximab contributed to the development of CMV infections is difficult to determine. Due to our concern about possible side-effects of cytopaenia with ganciclovir, we used acyclovir instead to treat the patient. Acyclovir has been reported only in prophylaxis and not the treatment of CMV infections (9) . The patient's lesions began to heal after a 10-day course of valacyclovir treatment, while tapering the dose of prednisolone to 10 mg daily and stopping the use of 0.05% clobetasol propionate ointment completely.
Concurrent Cytomegalovirus and Herpes Simplex Virus Infection in Pemphigus Vulgaris
Because frequent use of immunosuppressive treatments and extensive skin barrier defects may facilitate viral infections in patients with autoimmune bullous disorders (10), a sudden resistance to treatment should prompt a search for CMV and/or HSV infections, especially in areas with high seroprevalence of CMV. In Taiwan, the seroprevalence rate of CMV, as determined by a complement-fixation method, was 95% among adults (11). 
